Growth differentiation factor 15 is increased in stable MS

OBJECTIVE: To assess whether serum concentrations of the anti-inflammatory cytokine growth differentiation factor 15 (GDF-15) differ in patients with highly active multiple sclerosis (MS) vs patients with stable MS and healthy controls (HCs). METHODS: GDF-15 concentrations were measured by ELISA in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neurol Neuroimmunol Neuroinflamm
Autors principals: Amstad, Andrea, Coray, Mali, Frick, Corina, Barro, Christian, Oechtering, Johanna, Amann, Michael, Wischhusen, Jörg, Kappos, Ludwig, Naegelin, Yvonne, Kuhle, Jens, Mehling, Matthias
Format: Artigo
Idioma:Inglês
Publicat: Lippincott Williams & Wilkins 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7051204/
https://ncbi.nlm.nih.gov/pubmed/32024796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000675
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars